about
Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosisRoles of the metabolic syndrome, HDL cholesterol, and coronary atherosclerosis in subclinical inflammation.Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patients.Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitusToward a more professional and practical medical education: a novel Central European approachCoronary patients with high plasma omentin are at a higher cardiovascular risk.Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease.Comprehensive efforts to increase adherence to statin therapy.Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.Lipoprotein (a), the Metabolic Syndrome and Vascular Risk in Angiographied Coronary Patients.High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.Usefulness of serial decline of kidney function to predict mortality and cardiovascular events in patients undergoing coronary angiography.Eccentric endurance exercise economically improves metabolic and inflammatory risk factors.Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis.Prevalence of impaired glucose metabolism in individuals with peripheral arterial disease.Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease.Type 2 diabetes but not coronary atherosclerosis is an independent determinant of impaired mobility in angiographied coronary patientsAre AHSG polymorphisms directly associated with coronary atherosclerosis?Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery diseaseRelation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery diseaseType 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular eventsLow bone mineral density is not associated with angiographically determined coronary atherosclerosis in menLipid parameters in patients with acute coronary syndromes versus stable coronary artery diseasePlasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic controlIs albuminuria a myocardial infarction risk equivalent for atherothrombotic events?Impact of the albumin to creatinine ratio and the coronary artery state on vascular eventsThe age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
P50
Q33851293-44B4A90D-98A1-4C50-8617-3136F440306DQ34016134-B31CFAA4-F881-4E0F-B3A7-7EC74FFDCFE0Q34640574-9194984A-AF76-41DB-B49D-40C6434694E1Q35203823-3A075A65-8005-425F-A777-8FCBE3F26883Q35794447-667F6462-B3EA-4F38-8863-CE689E92E995Q36446038-00DA2EA4-D44F-4770-907A-D39AB0CEA46CQ37037878-C3E872B4-A450-4CA6-A70A-EF6FF64371E1Q39080414-F83745CB-7B5E-40F0-9457-099D432825FCQ39085863-15DB4A24-EAC7-4A00-918D-190FFC68527FQ39704605-4D759895-3037-4189-9394-C19384201277Q40293416-800EF01A-D161-4840-B5C4-7F668AEC5AB8Q41455151-F9910584-A9AC-4016-A631-A73FF6245321Q44118484-1885803A-B980-40C9-B7AC-3697A1B05FE4Q44708422-C08A02A9-23BC-46A7-B496-BFE7AA368332Q46043990-4A7177E6-5639-4335-BE86-F842518DCCCCQ46133441-9893B627-FE23-4111-A280-E91B216A5D52Q52967007-AF51DC47-BF4D-4CA4-8940-FA2096C9874DQ82174112-250782DB-B378-45A5-9690-AB870DD21EA2Q82177586-196463E0-58AD-45E5-A273-4F6C782C9582Q83409931-5DFD7050-D8C8-4BDA-BE0B-96CE8F31F879Q83418742-D78713F7-272B-4F8B-926F-BBF2B7427822Q83828215-8E6876AF-8ACC-45C6-9C88-228EAE7EE52BQ84948895-1A18FF9A-3310-4692-8ABE-6168D5C03363Q85858944-9E518448-3957-4364-801A-25577CD9147EQ86662060-CF473552-C795-428F-B51A-79FDF5256996Q86879640-C8A7A899-A0FD-4C4C-8A4F-10CEE497621BQ87607029-B99D9A18-D2E8-4AA0-BAA9-89FEB03A346CQ91824185-E7E3B5C0-4D4C-4A52-8925-7B779DCADCA6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexander Vonbank
@ast
Alexander Vonbank
@en
Alexander Vonbank
@es
Alexander Vonbank
@nl
type
label
Alexander Vonbank
@ast
Alexander Vonbank
@en
Alexander Vonbank
@es
Alexander Vonbank
@nl
prefLabel
Alexander Vonbank
@ast
Alexander Vonbank
@en
Alexander Vonbank
@es
Alexander Vonbank
@nl
P106
P21
P31
P496
0000-0001-5648-5623